Navigation Links
FDA approves Novartis drug Gleevec® label recommending extending treatment to three years for certain GIST patients after surgery
Date:2/1/2012

s to recommend consideration of at least three years of adjuvant therapy with Gleevec for patients with high-risk GIST(2).

In addition to extending the Gleevec label to three-year treatment duration in patients with KIT+ GIST after surgery, the FDA has agreed that all accelerated post-approval commitments for this indication have been met, confirming the clinical benefit of adjuvant treatment with Gleevec.

Study details
The SSG XVIII clinical trial was conducted by the Scandinavian Sarcoma Group (SSG) and the Sarcoma Group of the Arbeitsgemeinschaft Internistische Onkologie (AIO). This trial was a multicenter, prospective, randomized study for the evaluation of adjuvant treatment with Gleevec of histologically confirmed KIT+ GIST(5).

The primary endpoint of the study was to compare, within the first five years, recurrence-free survival in patients with a greater than 50% estimated risk of GIST disease recurrence, following diagnosis and treatment with adjuvant Gleevec for either 12 or 36 months. The secondary endpoints included overall survival and treatment safety(1).

Three hundred ninety-seven patients entered the study. Inclusion criteria for risk of recurrence was defined as tumor diameter >5.0 cm and mitotic count >5/50 high power fields (HPFs); or tumor diameter >10.0 cm, any mitotic count; or tumor of any size with a mitotic count >10/50 HPFs; or tumors ruptured into the peritoneal cavity.

Recurrence-free survival was longer in the 36-month group compared to the 12-month group (HR 0.46, 95% CI 0.32-0.65; p<0.0001). Patients assigned to 36 months of Gleevec after surgery had longer overall survival (HR 0.45, 95% CI 0.22-0.89; p=0.0187). Almost all patients experienced side effects while taking Gleevec. Gleevec was generally well tolerated. The proportion of patients who discontinued Gleevec during the assigned treatment period for reasons other than GIST recurrence was 26% over the full three yea
'/>"/>

SOURCE Novartis
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
3. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
4. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
5. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
6. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
7. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
8. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
9. U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
10. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
11. EPA Approves XDS-CALUX(R) as Alternate Dioxin Test Method 4435
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... New York , July 25, 2014 ... by Transparency Market Research "Global and China Insulin Market ... - Industry Analysis, Size, Share, Growth, Trends and Forecast ... market was valued at USD 19.99 billion in 2012 ... 6.1% from 2013 to 2019 to reach USD 32.24 ...
(Date:7/25/2014)... July 25, 2014  Semler Scientific, Inc. (Nasdaq: ... risk assessment company that develops patented products that ... chronic diseases, today reported financial results for the ... 2014. "The second quarter of ... Doug Murphy-Chutorian , M.D., chief executive officer ...
(Date:7/24/2014)...   AcelRx Pharmaceuticals, Inc.  (Nasdaq: ACRX ... and commercialization of innovative therapies for the treatment of ... for Zalviso remains July 27, 2014.  The ... the Food and Drug Administration (FDA) had approved Zalviso.  ... notification to the company from the FDA regarding the ...
Breaking Medicine Technology:Global Insulin Market Expected to Reach USD 32.24 Billion Globally in 2019: Transparency Market Research 2Global Insulin Market Expected to Reach USD 32.24 Billion Globally in 2019: Transparency Market Research 3Global Insulin Market Expected to Reach USD 32.24 Billion Globally in 2019: Transparency Market Research 4Semler Reports Second Quarter 2014 Financial Results 2Semler Reports Second Quarter 2014 Financial Results 3AcelRx Pharmaceuticals Confirms July 27, 2014 PDUFA Date for Zalviso 2
(Date:7/28/2014)... Alta Resources , a global provider of ... brands, announced today that it plans to fill more ... Florida and the Philippines. More than 600 of those ... A majority of the hiring is to support several ... staffing in preparation for the Annual Enrollment Period (AEP), ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 Labors.at, ... selected the hc1 Healthcare Relationship Cloud™ to fuel ... samples from up to 8,000 patients daily and ... anticipates further growth, up to doubling its volume ... completion of our cutting-edge 10,000 square meter facility ...
(Date:7/28/2014)... According to the Greek God Muscle Building Program review recently ... teaches men how to completely transform their physique by training ... review that inside the Greek God Muscle Building Program book, ... the maximum muscle fiber recovery , Low-budget ... , Ways to incorporate the specialization routines for ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 To commemorate ... Editorial Board of Living with a Disability magazine ... disabling digestive disorders that include hepatitis, gastrointestinal hemorrhage, inflammatory ... , The important new article highlights that, in the ... afflicted with hepatitis and other disabling conditions related to ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 Greta Pontarelli, 63, ... the Masters Champion title at the World Pole Sports Championships ... obstacle for this athlete. She is the only U.S. competitor ... the International Pole Sports Federation (IPSF). Over 150 athletes ranging ... took part in the competition. Pontarelli scored first place in ...
Breaking Medicine News(10 mins):Health News:Alta Resources To Fill Approximately 600 Positions In Neenah 2Health News:Alta Resources To Fill Approximately 600 Positions In Neenah 3Health News:Austrian Laboratory Leader, Labors.at, Fuels Growth with the hc1® Healthcare Relationship Cloud™ 2Health News:Greek God Muscle Building Program Review Exposes Greg O’Gallagher's Muscle Building Guide for Men – Vkool.com 2Health News:Greek God Muscle Building Program Review Exposes Greg O’Gallagher's Muscle Building Guide for Men – Vkool.com 3Health News:Living with a Disability Magazine Marks World Hepatitis Day on July 28 with New Article on Disabling Digestive Disorders 2Health News:Living with a Disability Magazine Marks World Hepatitis Day on July 28 with New Article on Disabling Digestive Disorders 3Health News:Inspiring Senior Athlete Lands Third World Title in One Year 2
... , ... VP for Healthcare Industry , ... Dayton, OH (Vocus) September 28, 2009 -- Sogeti, a leading international provider of professional IT ... Healthcare to further the industry expertise that it provides to clients., , ,With ...
... them, survey shows , MONDAY, Sept. 28 (HealthDay News) -- ... the growth charts widely used in pediatrician,s offices, but many ... a new survey shows. , About 85 percent of parents ... and correctly identify that the point corresponded to the child,s ...
... Life Care Centers ... 21., at its headquarters in Cleveland, Tenn. , ... Cleveland, Tenn. (Vocus) September 28, 2009 -- Life Care Centers of America ... its headquarters in Cleveland, Tenn., , ,The Chairman,s Award for outstanding commitment to excellence went ...
... ... a medical conference offered by the American Academy of Environmental Medicine in Phoenix, Arizona, October ... ... allergies have risen 24% among children under 5 years of age and 19% among children ...
... the number of women opting for surgery to remove the healthy ... a lack of evidence that the surgery can improve survival. The ... choose to have both breasts removed because of a strong family ... and has changed little in the last decade. The study appears ...
... Take precautions to avoid falls, strains and sprains, experts ... health and safety precautions when raking leaves, cleaning gutters ... according to the American Academy of Orthopaedic Surgeons (AAOS). ... the autumn season, and it often takes a toll ...
Cached Medicine News:Health News:Sogeti USA Grows to Ensure Industry Expertise for Clients 2Health News:Sogeti USA Grows to Ensure Industry Expertise for Clients 3Health News:Children's Growth Charts Don't Measure Up With Parents 2Health News:Children's Growth Charts Don't Measure Up With Parents 3Health News:Life Care Centers of America Awards Excellence 2Health News:Life Care Centers of America Awards Excellence 3Health News:Body Under Siege: Inflammation and Autoimmunity Conference Offered to Physicians 2Health News:Body Under Siege: Inflammation and Autoimmunity Conference Offered to Physicians 3Health News:Body Under Siege: Inflammation and Autoimmunity Conference Offered to Physicians 4Health News:More women choosing to remove healthy breast after cancer diagnosis 2Health News:Autumn Chores Often Hazardous 2
... The VHS® Variable- Angle CHS System ... fixation to the millennium. , ,The VHS® ... of your most difficult distal femur fractures ... unique features of the variable angle of ...
X-Hair Trephines...
Corneal Trephine Punch - Stainless steel unit with titanium jaws, complete with PTFE cutting block. 1 reusable unit....
Corneal Marker - 8 blades, 2 sizes available: 7.0mm, 8.0mm. 1 piece per box...
Medicine Products: